Publication:
Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection)

Issued Date

2020-01-01

Resource Type

Review

ISSN

25868470
25868195

DOI

10.29090/psa.2020.02.020.0026

Other identifier(s)

2-s2.0-85085214601

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Pharmaceutical Sciences Asia. Vol.47, No.2 (2020), 97-103

Suggested Citation

Nattapong Tidwong, Preecha Montakantikul, Weerawat Manosuthi Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection). Pharmaceutical Sciences Asia. Vol.47, No.2 (2020), 97-103. doi:10.29090/psa.2020.02.020.0026 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/56310

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection)

Author(s)

Nattapong Tidwong
 Preecha Montakantikul
 Weerawat Manosuthi

Other Contributor(s)

Mahidol University
 Chiang Mai University
 Bamrasnaradura Infectious Diseases Institute

Abstract

© Faculty of Pharmacy, Mahidol University (Thailand) 2020. As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development. Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS.

Keyword(s)

Medicine
 Pharmacology, Toxicology and Pharmaceutics

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/56310

Collections

Scopus 2020